LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 57

Search options

  1. Article ; Online: Con: freeze-all for all? One size does not fit all.

    Vuong, Lan N

    Human reproduction (Oxford, England)

    2022  Volume 37, Issue 7, Page(s) 1388–1393

    Abstract: IVF has traditionally involved transfer of fresh embryos. However, a 'freeze-all' strategy where all embryos are cryopreserved for transfer in subsequent, unstimulated cycles has emerged as an alternative approach. This is thought to eliminate the ... ...

    Abstract IVF has traditionally involved transfer of fresh embryos. However, a 'freeze-all' strategy where all embryos are cryopreserved for transfer in subsequent, unstimulated cycles has emerged as an alternative approach. This is thought to eliminate the negative effects of controlled ovarian stimulation on the endometrium and reduce the risk of ovarian hyperstimulation syndrome (OHSS). There are a growing number of studies evaluating live birth rates after use of a freeze-all versus fresh embryo transfer (ET) strategy. However, results to date are inconsistent. Certainly, the benefits of a freeze-all strategy appear to be less clear cut in ovulatory women with infertility, while those with a good ovarian response (more than 10 or 15 oocytes retrieved) may be suitable candidates. Variable responses to a freeze-all strategy compared with fresh ET have also been reported depending on whether cleavage stage embryos or blastocysts were transferred. In terms of safety, the risk of OHSS appears to be lower with a freeze-all strategy. For other safety endpoints, some appear to be better when a freeze-all approach is used (e.g. rates of pregnancy loss/miscarriage, preterm delivery, low birthweight and small for gestational age) while other complications are more common (e.g. hypertensive disorders of pregnancy/pre-eclampsia, large for gestational age and high birthweight). Preliminary longer-term data suggest that a freeze-all strategy does not have a negative impact on childhood development. Other factors to consider include time to pregnancy (longer after freeze-all) and the relative cost-effectiveness of the two approaches. Available data are too inconsistent to allow a freeze-all approach to be recommended for all patients. Instead, a personalized, balanced approach should be taken based on individual patient characteristics (especially steroid hormone levels on the day of trigger) and incorporating patient preference. While a freeze-all strategy might be the right choice for some patients, freeze-all is definitely not good for all.
    MeSH term(s) Abortion, Spontaneous ; Birth Rate ; Birth Weight ; Child ; Embryo Transfer/methods ; Female ; Fertilization in Vitro/methods ; Humans ; Ovarian Hyperstimulation Syndrome/etiology ; Ovarian Hyperstimulation Syndrome/prevention & control ; Ovulation Induction/adverse effects ; Ovulation Induction/methods ; Pregnancy ; Pregnancy Rate ; Retrospective Studies
    Language English
    Publishing date 2022-05-31
    Publishing country England
    Document type Journal Article
    ZDB-ID 632776-x
    ISSN 1460-2350 ; 0268-1161 ; 1477-741X
    ISSN (online) 1460-2350
    ISSN 0268-1161 ; 1477-741X
    DOI 10.1093/humrep/deac103
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Alteration of final maturation and laboratory techniques in low responders.

    Vuong, Lan N

    Fertility and sterility

    2022  Volume 117, Issue 4, Page(s) 675–681

    Abstract: The number and quality of embryos generated from the limited number of oocytes retrieved from low responders are important aspects of infertility treatment for these patients. This article focuses on 5 aspects relating to final maturation and laboratory ... ...

    Abstract The number and quality of embryos generated from the limited number of oocytes retrieved from low responders are important aspects of infertility treatment for these patients. This article focuses on 5 aspects relating to final maturation and laboratory techniques: follicular size at trigger, dual trigger, artificial oocyte activation (AOA), blastocyst transfer, and the role of preimplantation genetic testing for aneuploidy (PGT-A). There is lack of data regarding the role of follicular size, specifically in low-responder patients, but consideration should be given to using broader follicular size criteria when retrieving oocytes in this patient group. Use of dual trigger seems to be a good strategy in low-responder patients on the basis of initial evidence. Use of AOA with calcium ionophore may improve fertilization, embryonic development, and outcomes in cases with previous developmental problems. There is lack of data for low responders, but this promising technique deserves further study. In unselected patients, clinical trial data on blastocyst transfer are conflicting, and no high-quality studies have evaluated whether the live birth rate is higher after blastocyst transfer than after cleavage-stage embryo transfer in low responders. Specific evidence for PGT-A in low-responder patients is also lacking. Preimplantation genetic testing for aneuploidy should be considered in POSEIDON group 2 patients, especially those aged >38 years. Overall, applying the limited data available in combination with patient preference and individual patient characteristics will ensure a patient-centered and evidence-based approach that should optimize fertility outcomes for low responders.
    MeSH term(s) Aneuploidy ; Birth Rate ; Blastocyst ; Embryo Transfer ; Female ; Fertilization in Vitro/methods ; Humans ; Oocytes ; Pregnancy ; Pregnancy Rate ; Preimplantation Diagnosis/methods ; Retrospective Studies
    Language English
    Publishing date 2022-03-05
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80133-1
    ISSN 1556-5653 ; 0015-0282
    ISSN (online) 1556-5653
    ISSN 0015-0282
    DOI 10.1016/j.fertnstert.2022.01.028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Significance of serum AMH and antral follicle count discrepancy for the prediction of ovarian stimulation response in Poseidon criteria patients.

    Hochberg, Alyssa / Dahan, Michael H / Yarali, Hakan / Vuong, Lan N / Esteves, Sandro C

    Journal of assisted reproduction and genetics

    2024  Volume 41, Issue 3, Page(s) 717–726

    Abstract: Purpose: To determine the risk of not being a poor responder in ovarian stimulation (OS) for in vitro fertilization (IVF) when ovarian reserve markers are discordant-one falling within Poseidon's criteria normal range (e.g., anti-Müllerian hormone (AMH)  ...

    Abstract Purpose: To determine the risk of not being a poor responder in ovarian stimulation (OS) for in vitro fertilization (IVF) when ovarian reserve markers are discordant-one falling within Poseidon's criteria normal range (e.g., anti-Müllerian hormone (AMH) ≥ 1.2 ng/mL or antral follicle count (AFC) ≥ 5), and the other in the poor ovarian reserve range.
    Methods: A tri-center retrospective cohort study (2015-2017) involving women with discordant AMH and AFC values undergoing their first IVF/ICSI cycle using conventional OS (cOS, ≥ 150 IU/day of follicle-stimulating hormone). Discordant serum AMH and AFC values were defined according to Poseidon's criteria (AMH < 1.2 ng/mL and AFC ≥ 5 or AMH ≥ 1.2 ng/mL and AFC < 5). Poor ovarian response (POR) was < 4 retrieved oocytes. Receiver operating characteristic (ROC) curves were used to determine AMH and AFC cut-offs for non-POR. Logistic regression analysis evaluated factors associated with non-POR.
    Results: Out of 8797 patients who underwent assessment with both AMH and AFC, 1172 (13.3%) exhibited discordant values. Of these, 854 (72.9%) had ≥ 4 oocytes retrieved. Within this group, 726 (85.0%) had "low" AMH values, whereas 128 (15.0%) had "low" AFCs. An AFC of 6 had 77% sensitivity and 52% specificity (AUC = 0.700), while AMH of 1.19 ng/mL had 31% sensitivity and 85% specificity (AUC = 0.492) for non-POR. AFC and the use of recombinant gonadotropins were positive predictors of non-POR.
    Conclusions: When serum AMH is < 1.19 ng/mL, but AFC is ≥ 6, there is a moderate likelihood of a non-POR during stimulation. Conversely, if AFC is < 5 but serum AMH is ≥ 1.19 ng/mL, the chances of non-POR are low. Among patients with discordant markers, AFC emerges as the primary predictor of oocyte yield.
    MeSH term(s) Humans ; Female ; Ovarian Follicle/chemistry ; Anti-Mullerian Hormone ; Retrospective Studies ; Follicle Stimulating Hormone ; Fertilization in Vitro ; Ovulation Induction ; Ovarian Reserve
    Chemical Substances Anti-Mullerian Hormone (80497-65-0) ; Follicle Stimulating Hormone (9002-68-0)
    Language English
    Publishing date 2024-02-15
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1112577-9
    ISSN 1573-7330 ; 1058-0468
    ISSN (online) 1573-7330
    ISSN 1058-0468
    DOI 10.1007/s10815-024-03050-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: An update on the current indications for in vitro maturation.

    Ho, Vu N-A / Ho, Tuong M / Vuong, Lan N / García-Velasco, Juan

    Current opinion in obstetrics & gynecology

    2024  Volume 36, Issue 3, Page(s) 173–180

    Abstract: Purpose of review: In vitro maturation has become a significant component of modern assisted reproductive techniques. Published data have been supported for the safety and effectiveness of in vitro maturation treatment. In recent years, potential ... ...

    Abstract Purpose of review: In vitro maturation has become a significant component of modern assisted reproductive techniques. Published data have been supported for the safety and effectiveness of in vitro maturation treatment. In recent years, potential indications for in vitro maturation (IVM) have been a topic of interest and investigation.
    Recent findings: Significant improvements in technique enhancement and data publication for evaluating the efficacy of IVM have been achieved. Recent studies have shown that IVM could offer several advantages over in vitro fertilization. Currently, there are growing indications for IVM beyond the commonly mentioned indication of infertile women with polycystic ovary syndrome. Additionally, some potential candidates might have significant advantages for IVM, such as women diagnosed with gonadotropin resistance ovary syndrome or those seeking fertility preservation. With a better understanding of IVM, from basic science to clinical practice, it can be applied safely, effectively, and affordably to a broader range of patients, making it a more accessible and patient-friendly option.
    Summary: Despite the possibly acknowledged limitations, the potential of in vitro maturation cannot be denied. As this technique becomes increasingly accessible to patients and more continuous efforts are dedicated to advancing this technique, the impact of in vitro maturation is expected.
    MeSH term(s) Female ; Humans ; Pregnancy ; Fertility Preservation/methods ; Fertilization in Vitro ; In Vitro Oocyte Maturation Techniques ; Infertility, Female/therapy ; Polycystic Ovary Syndrome/complications
    Language English
    Publishing date 2024-01-31
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1049382-7
    ISSN 1473-656X ; 1040-872X
    ISSN (online) 1473-656X
    ISSN 1040-872X
    DOI 10.1097/GCO.0000000000000942
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Clinical factors associated with unexpected poor or suboptimal response in Poseidon criteria patients.

    Hochberg, Alyssa / Dahan, Michael H / Yarali, Hakan / Vuong, Lan N / Esteves, Sandro C

    Reproductive biomedicine online

    2024  Volume 49, Issue 1, Page(s) 103852

    Abstract: Research question: What clinical factors are associated with 'unexpected' poor or suboptimal responses to IVF ovarian stimulation per POSEIDON's criteria, and which AMH and AFC threshold values distinguish this population?: Design: Tri-centre ... ...

    Abstract Research question: What clinical factors are associated with 'unexpected' poor or suboptimal responses to IVF ovarian stimulation per POSEIDON's criteria, and which AMH and AFC threshold values distinguish this population?
    Design: Tri-centre retrospective cohort study (2015-2017) involving first-time IVF and ICSI cycles with conventional ovarian stimulation (≥150 IU/day of FSH). Eligibility criteria included sufficient ovarian reserve markers according to POSEIDON's classification (AMH ≥1.2 ng/ml; AFC ≥5). Ovarian response categories were poor (<4 oocytes), suboptimal (4-9 oocytes) and normal (≥9 oocytes). Primary outcomes included clinical factors associated with an unexpected poor or suboptimal response to conventional ovarian stimulation using logistic regression analyses, and the threshold values of AMH and AFC predicting increased risk of such responses using ROC curves.
    Results: A total of 7625 patients met the inclusion criteria: 204 (9.3%) were poor and 1998 (90.7%) were suboptimal responders. Logistic regression identified significant clinical predictors for a poor or suboptimal response, including AFC, AMH, total gonadotrophin dose, gonadotrophin type and trigger type (P ≤ 0.02). The ROC curves indicated that AMH 2.87 ng/ml (AUC 0.740) and AFC 12 (AUC 0.826) were the threshold values predicting a poor or suboptimal response; AMH 2.17 ng/ml (AUC 0.741) and AFC 9 (AUC 0.835) predicted a poor response; and AMH 2.97 ng/ml (AUC 0.722) and AFC 12 (AUC 0.801) predicted a suboptimal response.
    Conclusions: The threshold values of AMH and AFC predicting 'unexpected' poor or suboptimal response were higher than expected. These findings have critical implications for tailoring IVF stimulation regimens and dosages.
    Language English
    Publishing date 2024-01-30
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2113823-0
    ISSN 1472-6491 ; 1472-6483
    ISSN (online) 1472-6491
    ISSN 1472-6483
    DOI 10.1016/j.rbmo.2024.103852
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Outcomes of clinical in vitro maturation programs for treating infertility in hyper responders: a systematic review.

    Vuong, Lan N / Pham, Toan D / Ho, Tuong M / De Vos, Michel

    Fertility and sterility

    2023  Volume 119, Issue 4, Page(s) 540–549

    Abstract: Oocyte in vitro maturation (IVM) has been proposed as an alternative to conventional ovarian stimulation (COS) in subfertile women with polycystic ovary syndrome. To evaluate the effectiveness and safety of IVM compared with COS in women with predicted ... ...

    Abstract Oocyte in vitro maturation (IVM) has been proposed as an alternative to conventional ovarian stimulation (COS) in subfertile women with polycystic ovary syndrome. To evaluate the effectiveness and safety of IVM compared with COS in women with predicted hyperresponse to gonadotropins, we searched the published literature for relevant studies comparing any IVM protocol with any COS protocol followed by in vitro fertilization or intracytoplasmic sperm injection. A systematic review was undertaken on 3 eligible prospective studies. Live birth rate was not significantly lower after IVM vs. COS (odds ratio [95% confidence interval] of 0.56 [0.32-1.01] overall, 0.83 [0.63-1.10] for human chorionic gonadotropin (hCG)-triggered IVM [hCG-IVM] and 0.45 [0.18-1.13] for non-hCG-triggered IVM [non-hCG-IVM]), irrespective of the stage of transferred embryos. Data from nonrandomized studies generally showed either significantly low or statistically comparable rates of live birth with IVM vs. COS. Most studies have not identified any significant difference between IVM and COS with respect to the rates of obstetric or perinatal complications, apart from a potentially higher rate of hypertensive disorders during pregnancy. The development of offspring from IVM and COS with in vitro fertilization or intracytoplasmic sperm injection appears to be similar. Additional research is needed to identify which patient populations will benefit most from IVM, to define the appropriate clinical protocol, and to develop the optimal culture system.
    MeSH term(s) Male ; Pregnancy ; Female ; Humans ; Prospective Studies ; Semen ; Fertilization in Vitro/adverse effects ; Fertilization in Vitro/methods ; In Vitro Oocyte Maturation Techniques/methods ; Chorionic Gonadotropin ; Infertility, Female/therapy ; Infertility, Female/drug therapy ; Pregnancy Rate ; Polycystic Ovary Syndrome/complications ; Oocytes
    Chemical Substances Chorionic Gonadotropin
    Language English
    Publishing date 2023-02-06
    Publishing country United States
    Document type Systematic Review ; Journal Article ; Review
    ZDB-ID 80133-1
    ISSN 1556-5653 ; 0015-0282
    ISSN (online) 1556-5653
    ISSN 0015-0282
    DOI 10.1016/j.fertnstert.2023.01.046
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Development of children born after in vitro maturation with a prematuration step versus natural conception: a prospective cohort study.

    Nguyen, Duy L / Nguyen, Nghia A / Pham, Toan D / Nguyen, Minh H N / Vuong, Lan N

    Journal of assisted reproduction and genetics

    2022  Volume 39, Issue 8, Page(s) 1959–1965

    Abstract: Purpose: IVM preceded by a prematuration step (capacitation [CAPA]-IVM) improves the acquisition of oocyte developmental competence and can enhance embryo quality. There is currently no follow-up data on babies born from CAPA-IVM. This study ... ...

    Abstract Purpose: IVM preceded by a prematuration step (capacitation [CAPA]-IVM) improves the acquisition of oocyte developmental competence and can enhance embryo quality. There is currently no follow-up data on babies born from CAPA-IVM. This study investigated developmental outcomes in children born after CAPA-IVM versus natural conception.
    Methods: This prospective cohort study was conducted at a fertility clinic in Vietnam in August/September 2019. Children born after CAPA-IVM were propensity score-matched with those born after natural conception. All parents were asked to complete the Developmental Red Flags and Ages & Stages Third Edition (ASQ-3) questionnaires.
    Results: A total of 46 parents (23 in each group) of 55 babies (31 CAPA-IVM and 24 natural conception) were included in the study. Baseline characteristics, including mother's age and body mass index, gestational age at delivery, and birth weight, were comparable. The mean age of children at the end of follow-up was 15 months. The overall proportion of children with any abnormal ASQ-3 score was 6.5% in the CAPA-IVM group and 20.8% in the natural conception group (p = 0.24). The proportion of children with a developmental red flag did not differ significantly between the CAPA-IVM and natural conception groups (9.7% vs. 4.2%; p = 0.80).
    Conclusions: The use of CAPA-IVM did not have any significant impact on childhood physical and mental development compared with children born as a result of natural conception.
    MeSH term(s) Fertilization in Vitro ; Humans ; In Vitro Oocyte Maturation Techniques ; Oocytes ; Oogenesis ; Prospective Studies
    Language English
    Publishing date 2022-07-07
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1112577-9
    ISSN 1573-7330 ; 1058-0468
    ISSN (online) 1573-7330
    ISSN 1058-0468
    DOI 10.1007/s10815-022-02559-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: POSEIDON groups and their distinct reproductive outcomes: Effectiveness and cost-effectiveness insights from real-world data research.

    Esteves, Sandro C / Yarali, Hakan / Vuong, Lan N / Conforti, Alessandro / Humaidan, Peter / Alviggi, Carlo

    Best practice & research. Clinical obstetrics & gynaecology

    2022  Volume 85, Issue Pt B, Page(s) 159–187

    Abstract: The Patient-Oriented Strategies Encompassing IndividualizeDOocyte Number (POSEIDON) criteria identify and classify the so-called 'low-prognosis' patients undergoing assisted reproductive technology (ART). Recent large-scale studies using real-world data ( ...

    Abstract The Patient-Oriented Strategies Encompassing IndividualizeDOocyte Number (POSEIDON) criteria identify and classify the so-called 'low-prognosis' patients undergoing assisted reproductive technology (ART). Recent large-scale studies using real-world data (RWD) have shown that patients classified under this system have distinct reproductive outcomes. Moreover, these studies also confirm that POSEIDON patients are commonly found in fertility centers. RWD has substantiated the validity of the POSEIDON biomarkers' thresholds (antral follicle count [AFC] and/or anti-Müllerian hormone [AMH]) for patient classification. Lastly, a predictive model has been developed and validated to estimate the POSEIDON metric of success (i.e., number of oocytes needed to achieve at least one euploid blastocyst). Although more evidence is needed in this area, current insights from RWD research indicate that infertility patients can be counseled and managed more effectively under the POSEIDON scope, with potential gains for all parties involved.
    Language English
    Publishing date 2022-05-19
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2050090-7
    ISSN 1532-1932 ; 1521-6934
    ISSN (online) 1532-1932
    ISSN 1521-6934
    DOI 10.1016/j.bpobgyn.2022.05.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Embryological and clinical outcomes in couples with severe male factor infertility versus normozoospermia.

    Le, Phuong T B / Nguyen, Trinh T T / Dang, Trang T H / Nguyen, Tri C / Duong, Toan P / Le, Anh H / Ho, Tuong M / Vuong, Lan N

    European journal of obstetrics, gynecology, and reproductive biology

    2024  Volume 294, Page(s) 123–127

    Abstract: Objective: This study evaluated embryological and clinical outcomes in couples with severe male factor infertility versus those with normozoospermia undergoing ICSI and in vitro fertilisation.: Methods: This multicentre, retrospective cohort study ... ...

    Abstract Objective: This study evaluated embryological and clinical outcomes in couples with severe male factor infertility versus those with normozoospermia undergoing ICSI and in vitro fertilisation.
    Methods: This multicentre, retrospective cohort study included all couples who had undergone autologous ICSI cycles at My Duc Hospital and My Duc Phu Nhuan Hospital in Vietnam between January 2018 and January 2021 (female age < 35 years and males with severe male factor or normozoospermia based on the World Health Organization 2010 criteria). The primary outcome was the cumulative live birth rate after the first ICSI cycle.
    Results: A total of 1296 couples were included, including 648 with severe male factor infertility and 648 with normozoospermia. The number of two pronuclei zygotes, embryos, and frozen embryos was significantly lower in couples with severe male factor infertility compared with normozoospermia (p < 0.05). In contrast, there were no significant differences between the two groups with respect to cumulative pregnancy outcomes, including the live birth rate, and secondary outcomes including clinical pregnancy rate, ongoing pregnancy rate, and miscarriage rate.
    Conclusion: Severe male factor infertility appeared to have an impact on the fertilisation and early developmental potential of embryos, but sperm quality did not affect cumulative clinical fertility outcomes.
    MeSH term(s) Pregnancy ; Male ; Humans ; Female ; Adult ; Sperm Injections, Intracytoplasmic/methods ; Retrospective Studies ; Semen ; Infertility, Male/therapy ; Fertilization in Vitro/methods ; Pregnancy Rate ; Birth Rate ; Live Birth ; Infertility
    Language English
    Publishing date 2024-01-14
    Publishing country Ireland
    Document type Multicenter Study ; Journal Article
    ZDB-ID 190605-7
    ISSN 1872-7654 ; 0301-2115 ; 0028-2243
    ISSN (online) 1872-7654
    ISSN 0301-2115 ; 0028-2243
    DOI 10.1016/j.ejogrb.2024.01.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Intracytoplasmic sperm injection for all or for a few?

    Franasiak, Jason M / Polyzos, Nikolaos P / Neves, Ana Raquel / Yovich, John Liu / Ho, Tuong M / Vuong, Lan N / Norman, Robert J

    Fertility and sterility

    2022  Volume 117, Issue 2, Page(s) 270–284

    MeSH term(s) Clinical Decision-Making ; Female ; Fertility ; Humans ; Infertility/diagnosis ; Infertility/physiopathology ; Infertility/therapy ; Male ; Medical Overuse/trends ; Patient Selection ; Practice Patterns, Physicians'/trends ; Pregnancy ; Sperm Injections, Intracytoplasmic/adverse effects ; Sperm Injections, Intracytoplasmic/trends ; Time Factors ; Treatment Outcome
    Language English
    Publishing date 2022-02-06
    Publishing country United States
    Document type Editorial
    ZDB-ID 80133-1
    ISSN 1556-5653 ; 0015-0282
    ISSN (online) 1556-5653
    ISSN 0015-0282
    DOI 10.1016/j.fertnstert.2021.12.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top